Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xiangkun Xie"'
Autor:
Xiangkun Xie, Mingwei Yang, Shan Xie, Xiaoying Wu, Yuan Jiang, Zhaoyu Liu, Huiying Zhao, Yangxin Chen, Yuling Zhang, Jingfeng Wang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Introduction: Left ventricular reverse remodeling (LVRR) is associated with decreased cardiovascular mortality and improved cardiac survival and also crucial for therapeutic options. However, there is a lack of an early prediction model of LVRR in fi
Externí odkaz:
https://doaj.org/article/384a61b06bfc46679f305106d629a097
Autor:
Ayiguli Abudukeremu, Canxia Huang, Hongwei Li, Runlu Sun, Xiao Liu, Xiaoying Wu, Xiangkun Xie, Jingjing Huang, Jie Zhang, Jinlan Bao, Yuling Zhang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Although elevation of HDL-C levels by pharmaceutical drugs have no benefit of cardiovascular endpoint, the effect of high-density lipoprotein/apolipoprotein A1 (HDL/apoA-1) replacement therapy on atherosclerosis is controversial. The curr
Externí odkaz:
https://doaj.org/article/87ee656023c94e079d56f4c28c7b8c4c
Autor:
Zhengliang Peng, Qiong Zhan, Xiangkun Xie, Hanlin Li, Yan Tu, Yujia Bai, Xingfu Huang, Wenyan Lai, Boxin Zhao, Qingchun Zeng, Dingli Xu
Publikováno v:
Molecular Medicine, Vol 25, Iss 1, Pp 1-9 (2019)
Abstract Background 2-oxoglutarate (2OG), an intermediate metabolite in the tricarboxylic acid cycle, has been found to associate with chronic heart failure (HF), but its effect on short-term adverse outcomes in patients with acute HF (AHF) is uncert
Externí odkaz:
https://doaj.org/article/412d032f49fd4403a1d2e21001653f51
Autor:
Yangxin Chen, Mengling Qi, Xinfeng Wang, Xiao Liu, Wenhao Liu, Zhiteng Chen, Maoxiong Wu, Qi Guo, Liqun Wu, Wei Xu, Yangang Su, Keping Chen, Qian Chen, Xiangkun Xie, Zhengyu Cao, Xiaoying Wu, Jingting Mai, Yinyin Zhang, Hong Pan, Yuedong Yang, Yuling Zhang, Huiying Zhao, Jing-Feng Wang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e015b824108c4da4fe932040a7bcc627
https://doi.org/10.2139/ssrn.4436228
https://doi.org/10.2139/ssrn.4436228
Autor:
Xiangkun Xie1,2,3 (AUTHOR), Zhengliang Peng1,4 (AUTHOR), Hanlin Li1 (AUTHOR), Dan Li5 (AUTHOR), Yan Tu1 (AUTHOR), Yujia Bai1 (AUTHOR), Xingfu Huang1 (AUTHOR), Wenyan Lai1 (AUTHOR), Qiong Zhan1 (AUTHOR), Qingchun Zeng1 (AUTHOR), Dingli Xu1 (AUTHOR) dlxugz@163.com
Publikováno v:
BioMed Research International. 1/21/2020, p1-9. 9p. 1 Diagram, 5 Charts, 1 Graph.
Autor:
Hongwei Li, Jie Zhang, Qi Guo, Wei Xie, Xiaoying Zhan, Qian Chen, Xiangkun Xie, Runlu Sun, Zhengyu Cao, Yuan Jiang, Xiaolin Xu, Yuling Zhang
Publikováno v:
Journal of Diabetes and its Complications. 37:108381
Impaired glycolipid metabolism can induce vascular injury and plaque formation. It is important to investigate the associations between carotid plaque progression and lipid-lowering goal achievement and cardiovascular disease.Diabetic patients who un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f69d3f7599806082e17e0cfbf1d6bef
https://doi.org/10.1016/j.jdiacomp.2022.108381
https://doi.org/10.1016/j.jdiacomp.2022.108381
Autor:
Qiong Zhan, Qingchun Zeng, Hanlin Li, Tu Yan, Dingli Xu, Zhengliang Peng, Yujia Bai, Xiangkun Xie, Boxin Zhao, Xingfu Huang, Wenyan Lai
Publikováno v:
Molecular Medicine, Vol 25, Iss 1, Pp 1-9 (2019)
Molecular Medicine
Molecular Medicine
Background 2-oxoglutarate (2OG), an intermediate metabolite in the tricarboxylic acid cycle, has been found to associate with chronic heart failure (HF), but its effect on short-term adverse outcomes in patients with acute HF (AHF) is uncertain. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044711d8ecd59c372e6e02a35a17ac08
http://link.springer.com/article/10.1186/s10020-019-0078-1
http://link.springer.com/article/10.1186/s10020-019-0078-1
Autor:
Junjie Wang, Xiangkun Xie, Jingjing Huang, Qingqun Chen, Yuan Jiang, Yuling Zhang, Zhijian He, Jingfeng Wang, Runlu Sun, Jinlan Bao, Xiaoying Wu
Publikováno v:
Ann Transl Med
BACKGROUND: This study investigated whether combinations of high-density lipoprotein (HDL) subfractions and inflammatory markers would add value to coronary artery disease (CAD) prediction. METHODS: Non-CAD subjects (n=245) were stratified into low/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09667fa77f435b26dcb3328071387517
https://pubmed.ncbi.nlm.nih.gov/33987370
https://pubmed.ncbi.nlm.nih.gov/33987370
Autor:
Jinlan Bao, Jinglu Zhang, Xiangkun Xie, Shiliang Yang, Yuling Zhang, Jingjing Huang, Shaoxin Zheng, Xiaoying Wu
Publikováno v:
Annals of palliative medicine. 10(6)
BACKGROUND High levels of lipoprotein(a) (Lp(a)) is an independent risk factor for premature coronary heart disease (PCHD). It is also considered a residual risk for controlled low density lipoprotein cholesterol (LDL-C). Dietary control, exercise, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af4de07c8a8987f8641744da7fbeeeb
https://pubmed.ncbi.nlm.nih.gov/34237965
https://pubmed.ncbi.nlm.nih.gov/34237965
Autor:
Jieyu Jiang, Junjie Wang, Xiangkun Xie, Jinlan Bao, Qi Guo, Xiaoying Wu, Pu Fang, Hong Wang, Canxia Huang, Yuling Zhang, Yuan Jiang, Chen Qian, Runlu Sun, Jingfeng Wang, Hongwei Li
Publikováno v:
Cardiovascular drugs and therapy. 36(4)
Purpose Intracellular cholesterol imbalance plays an important role in adipocyte dysfunction of obesity. However, it is unclear whether obesity induced monocyte chemoattractant protein-1 (MCP-1) causes the adipocyte cholesterol imbalance. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a856b0e284366c95940ccead13b6afdd
https://pubmed.ncbi.nlm.nih.gov/33740174
https://pubmed.ncbi.nlm.nih.gov/33740174